Levetiracetam Tablet, Film Coated
Product Images NDC 72205-094

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 72205-094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetam-tablets-1000-mg-60s-count (Levetiracetam Tablets 1000 mg 60s Count)

Levetiracetam Tablets, USP 1000 mg film-coated tablets package label. The label indicates the product is distributed by Novadoz Pharmaceuticals LLC and manufactured by MSN Laboratories Private Limited. It includes storage instructions, pharmacist dispensing guidance, and a note to provide the medication guide with the product. Package contains 60 tablets.*

FDA Label Image

Levetiracetam-tablets-250-mg-120s-count (Levetiracetam Tablets 250 mg 120s Count)

Levetiracetam 250 mg film-coated tablets label showing 120 tablets per container. The label includes storage instructions, pharmacist dispensing advice, and manufacturer/distributor information. Manufactured by MSN Laboratories Private Limited and distributed by Novadoz Pharmaceuticals LLC. Contains barcodes and a note to dispense the accompanying Medication Guide.*

FDA Label Image

Levetiracetam-tablets-500-mg-120s-count (Levetiracetam Tablets 500 mg 120s Count)

Levetiracetam Tablets USP, 500 mg film-coated oral tablets. The label shows the NDC 72205-095-92 and states it contains 120 tablets. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC. Includes pharmacist instructions for storage and handling, and a note to dispense the Medication Guide to patients.*

FDA Label Image

Levetiracetam-tablets-750-mg-120s-count (Levetiracetam Tablets 750 mg 120s Count)

Levetiracetam Tablets, USP 750 mg film-coated tablets label displaying NDC 72205-096-92. The label shows a quantity of 120 tablets and indicates the drug is distributed by Novadoz Pharmaceuticals LLC. Manufacturer is MSN Laboratories Private Limited, India. The label includes storage instructions, pharmacist dispensing information, and a medication guide notice.*

FDA Label Image

Levetiracetam-tablets-figure-1 (Levetiracetam Tablets Figure 1)

A bar chart displaying the percentage of patients across three groups: Placebo (7.4%, N=95), Levetiracetam 1000 mg/day (37.1%, N=97), and Levetiracetam 3000 mg/day (39.6%, N=101). The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Levetiracetam-tablets-figure-2 (Levetiracetam Tablets Figure 2)

A bar chart comparing the percentage of patients across three groups: Placebo (6.3% of 111 patients), Levetiracetam 1000 mg/day (20.8% of 106 patients), and Levetiracetam 2000 mg/day (35.2% of 105 patients). The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Levetiracetam-tablets-figure-3 (Levetiracetam Tablets Figure 3)

A bar chart comparing the percentage of patients between two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The y-axis represents the percentage of patients from 0% to 45%. The Placebo group shows 14.4%, while the Levetiracetam group shows 39.4% with an asterisk indicating statistical significance.*

FDA Label Image

Levetiracetam-tablets-figure-4 (Levetiracetam Tablets Figure 4)

A bar graph comparing the percentage of patients between two groups: Placebo (N=97) and Levetiracetam (N=101). The y-axis represents the percentage of patients, with the Placebo group showing 19.6% and the Levetiracetam group showing 44.6%. The graph highlights a notable difference between the two groups.*

FDA Label Image

Levetiracetam-tablets-figure-5 (Levetiracetam Tablets Figure 5)

A bar graph comparing the percentage of patients between two groups: Placebo (N=51) with 19.6% and Levetiracetam (N=58) with 43.1%. The y-axis shows percentage of patients ranging from 0% to 45%. Each group is represented by a separate bar indicating patient percentages.*

FDA Label Image

Levetiracetam-tablets-figure-6 (Levetiracetam Tablets Figure 6)

A bar chart comparing the percentage of patients in two groups: Placebo (N=84) with 45.2% and Levetiracetam (N=79) with 72.2%. The y-axis represents the percentage of patients from 0% to 100%. The chart indicates a higher percentage for the Levetiracetam group compared to the Placebo group.*

FDA Label Image

Levetiracetam-tablets-structure (Levetiracetam Tablets Structure)

Chemical structure of Levetiracetam showing the molecular arrangement including a pyrrolidone ring attached to an amino acid skeleton with characteristic carbonyl and amino groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.